FDA Inspection 1292954 — Emmanuel S. Ferrer II, M.D.
The FDA completed an inspection of Emmanuel S. Ferrer II, M.D. on Nov 18, 2025 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional details
Clinical BA/BE